Latest Insider Transactions at Relay Therapeutics, Inc. (RLAY)
This section provides a real-time view of insider transactions for Relay Therapeutics, Inc. (RLAY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Relay Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Relay Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
Andy Porter Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
294
-0.62%
|
$8,526
$29.87 P/Share
|
|
Mar 24
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
10,000
-9.53%
|
$300,000
$30.0 P/Share
|
|
Mar 24
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.7%
|
$40,000
$4.12 P/Share
|
|
Mar 24
2022
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,286
-19.67%
|
$398,580
$30.0 P/Share
|
|
Mar 24
2022
|
Thomas Catinazzo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,286
+16.44%
|
$53,144
$4.12 P/Share
|
|
Mar 10
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
10,000
-9.53%
|
$250,000
$25.0 P/Share
|
|
Mar 10
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.7%
|
$40,000
$4.12 P/Share
|
|
Mar 01
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
8,000
-7.77%
|
$184,000
$23.88 P/Share
|
|
Mar 01
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+7.21%
|
$32,000
$4.12 P/Share
|
|
Feb 22
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
22,994
-6.91%
|
$459,880
$20.95 P/Share
|
|
Feb 22
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+6.35%
|
$32,000
$4.12 P/Share
|
|
Jan 27
2022
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,270
+37.69%
|
-
|
|
Jan 27
2022
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
64,950
+37.14%
|
-
|
|
Jan 27
2022
|
Thomas Catinazzo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,270
+41.99%
|
-
|
|
Jan 27
2022
|
Andy Porter Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,170
+33.81%
|
-
|
|
Dec 31
2021
|
Sanjiv Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
658
+0.26%
|
$17,108
$26.1 P/Share
|
|
Dec 31
2021
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
658
+2.5%
|
$17,108
$26.1 P/Share
|
|
Dec 27
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
295
-1.17%
|
$9,735
$33.1 P/Share
|
|
Dec 27
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
649
-1.42%
|
$21,417
$33.1 P/Share
|
|
Dec 27
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
295
-1.93%
|
$9,735
$33.1 P/Share
|
|
Dec 27
2021
|
Andy Porter Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
260
-1.11%
|
$8,580
$33.1 P/Share
|
|
Nov 15
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-20.45%
|
$227,500
$35.42 P/Share
|
|
Nov 15
2021
|
Brian Adams Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+16.98%
|
$26,000
$4.12 P/Share
|
|
Nov 15
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-59.55%
|
$787,500
$35.4 P/Share
|
|
Nov 15
2021
|
Thomas Catinazzo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+37.32%
|
$90,000
$4.12 P/Share
|
|
Oct 15
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
30,000
-39.67%
|
$1,020,000
$34.15 P/Share
|
|
Sep 27
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
293
-1.15%
|
$10,548
$36.87 P/Share
|
|
Sep 27
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
646
-0.85%
|
$23,256
$36.87 P/Share
|
|
Sep 27
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
293
-1.88%
|
$10,548
$36.87 P/Share
|
|
Sep 13
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-59.09%
|
$787,500
$35.0 P/Share
|
|
Sep 13
2021
|
Thomas Catinazzo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+37.14%
|
$90,000
$4.12 P/Share
|
|
Sep 13
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-20.26%
|
$227,500
$35.02 P/Share
|
|
Sep 13
2021
|
Brian Adams Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+16.85%
|
$26,000
$4.12 P/Share
|
|
Jun 28
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
976
-1.26%
|
$34,160
$35.81 P/Share
|
|
Jun 28
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
293
-1.85%
|
$10,255
$35.81 P/Share
|
|
Jun 28
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
293
-1.13%
|
$10,255
$35.81 P/Share
|
|
Jun 16
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
42,242
-35.35%
|
$1,393,986
$33.75 P/Share
|
|
Jun 16
2021
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
42,242
+26.12%
|
$168,968
$4.12 P/Share
|
|
Jun 07
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-58.64%
|
$787,500
$35.0 P/Share
|
|
Jun 07
2021
|
Thomas Catinazzo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+36.96%
|
$90,000
$4.12 P/Share
|
|
Jun 07
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-20.08%
|
$227,500
$35.0 P/Share
|
|
Jun 07
2021
|
Brian Adams Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+16.72%
|
$26,000
$4.12 P/Share
|
|
Apr 26
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-20.08%
|
$227,500
$35.0 P/Share
|
|
Apr 26
2021
|
Brian Adams Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+16.72%
|
$26,000
$4.12 P/Share
|
|
Apr 16
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
56,324
-42.17%
|
$1,802,368
$32.36 P/Share
|
|
Mar 30
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-100.0%
|
$787,500
$35.0 P/Share
|
|
Mar 30
2021
|
Thomas Catinazzo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+50.0%
|
$90,000
$4.12 P/Share
|
|
Mar 26
2021
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,870
+38.02%
|
-
|
|
Mar 26
2021
|
Thomas Catinazzo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,870
+50.0%
|
-
|
|
Mar 26
2021
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
34,999
+20.76%
|
-
|